| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33587321_HAS_TOPIC_C0005492> <https://research.tib.eu/covid-19/entity/33587321_HAS_TOPIC_C0007603> <https://research.tib.eu/covid-19/entity/33587321_HAS_TOPIC_C0032119> <https://research.tib.eu/covid-19/entity/33587321_HAS_TOPIC_C0033618> <https://research.tib.eu/covid-19/entity/33587321_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33587321_HAS_TOPIC_C0596577> <https://research.tib.eu/covid-19/entity/33587321_HAS_TOPIC_C0960880> <https://research.tib.eu/covid-19/entity/33587321_HAS_TOPIC_C1025331> <https://research.tib.eu/covid-19/entity/33587321_HAS_TOPIC_C2936239> <https://research.tib.eu/covid-19/entity/33587321_HAS_TOPIC_C3494273> <https://research.tib.eu/covid-19/entity/33587321_HAS_TOPIC_C3494274> <https://research.tib.eu/covid-19/entity/33587321_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33587321_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/33587321_HAS_TOPIC_C5392141> <https://research.tib.eu/covid-19/entity/33587321_HAS_TOPIC_C5392994>
?:authorAffiliation	[\'School of Pharmacy, Xi\'an Jiaotong University, Xi\'an, China.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Ding_Yuanyuan> <https://research.tib.eu/covid-19/entity/Gao_Jiapan> <https://research.tib.eu/covid-19/entity/Liang_Peida> <https://research.tib.eu/covid-19/entity/Liu_Rui> <https://research.tib.eu/covid-19/entity/Wang_Yuejin> <https://research.tib.eu/covid-19/entity/Zhang_Liyang>
?:doi	10.1002/ptr.7030
?:doi	<https://research.tib.eu/covid-19/entity/10.1002/ptr.7030>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article>
?:journal	Phytotherapy research : PTR
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33587321>
?:pmid	<https://research.tib.eu/covid-19/entity/33587321>
?:pmid	33587321
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C0658374_INTERACTS_WITH_C1422064> <https://research.tib.eu/covid-19/entity/C1175743_LOCATION_OF_C1422064>
?:title	Oroxylin A is a severe acute respiratory syndrome coronavirus 2-spiked pseudotyped virus blocker obtained from Radix Scutellariae using angiotensin-converting enzyme II/cell membrane chromatography.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33587321>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33587321>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all